ISRCTN16228603已完成未知
ONgoing Telmisartan Alone or in combination with Ramipril Global Endpoint Trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 31,546
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adults greater than or equal to 55 years
- •2. With a history of symptomatic coronary artery disease, cerebrovascular disease, peripheral vascular disease, or diabetes mellitus
- •3. Coronary Artery Disease: previous MI (greater than 2 days prior to informed consent), or stable or previous unstable angina (greater than 30 days prior to informed consent) with documented multivessel coronary artery disease or a positive stress test, or multivessel Percutaneous Transluminal Coronary Angioplasty (PTCA) (greater than 30 days prior to informed consent), or previous multivessel Coronary Artery Bypass Graft (CABG) without angina (if surgery performed greater than 4 years prior to informed consent) or with recurrent angina after surgery
- •4. No definite and specific indication or contraindication for any of the study treatments
- •5. Written informed consent
- •Other High Risk:
- •6. Peripheral Arterial Disease: previous limb bypass surgery or angioplasty or amputation, intermittent claudication on history with ankle/arm Blood Pressure (BP) ratio less than 0.8 on at least one side, or significant stenosis by angiography or non-invasive testing
- •7. Previous stroke
- •8. Transient Ischaemic Attach (TIA) greater than 7 days and less than 1 year prior to informed consent
- •9. Diabetes Mellitus (types I or II): with evidence of end-organ damage (retinopathy, Left Ventricular Hypertrophy [LVH], micro- or macro-albuminuria), or any evidence of previous cardiac or vascular disease
排除标准
- •Does not match inclusion criteria
研究者
相似试验
招募中
不适用
To see the Effect of Telmisartan and Telmisartan in combination with Hydrochlorthiazide on kidney functions and serum electrolytes in patients of Essential HypertensioCTRI/2018/01/011091Atul Patel
已完成
4 期
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.Cardiovascular DiseasesNCT00153101Boehringer Ingelheim31,546
招募中
1 期
Effects of single-pill combination of telmisartan/amlodipine and telmisartan/amlodipine/hydrochlorothiazide on 24-hour blood pressure (BP) reduction, 24-h BP variability and office BP control in patients with arterial hypertension – SATELLITEArterial hypertensionMedDRA version: 21.1Level: LLTClassification code: 10081425Term: Arterial hypertension Class: 10047065CTIS2023-504812-13-00KRKA tovarna zdravil d.d. Novo mesto191
已完成
不适用
Effect of a standard dose of telmisartan combined with amlodipine and trichlormethiazide versus a high dose of telmisartan combined with trichlormethiazide on urinary excretion of albumin in hypertensive patients with type 2 diabetes mellitusType 2 diabetic patients with essential hypertension and albuminuriaJPRN-UMIN000005170agoya City University Graduate School of Medical Sciences40
尚未招募
3 期
Comparing effect of telmisartan morning bedtime and divided doses in patients with high blood pressureCTRI/2024/02/062737on funded study All India Institute of medical sciences Jodhpur